As a psychoactive substance abused worldwide, methamphetamine (METH) abuse leads to
multiple neurodegenerative symptoms including memory deficits. Terminalia chebula retzius …

Background Stimulant use has increased across the US, with concomitant opioid and
methamphetamine use doubling between 2011 and 2017. Shifting patterns of …

Rationale The growing prevalence of psychostimulant (including amphetamine) use and
associated health harms, with limited treatment options, present a global challenge. There is …

Background For people with opioid use disorder who are not responding to oral opioid
agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment …

Objectives Contingency management (CM) is one of the most effective treatments for
stimulant use disorder but has not been leveraged for people with stimulant-associated …

Methamphetamine use is surging globally as a cause of morbidity and mortality. Treatment
is typically sought in early abstinence, when craving and depressive symptoms are intense …

Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction,
including interventions that focus on prescribing pharmaceutical-grade psychoactive …

Introduction Methamphetamine (MA) use disorder is an important public health concern. MA
withdrawal is often the first step in ceasing or reducing use. There are no evidence-based …

Background: Methamphetamine use disorder (MUD) is a growing health concern with no
FDA-approved treatment. The present series of studies build upon our previous work …

Objectives: We assessed the efficacy of cognitive behavioral therapy and bupropion
compared to cognitive behavioral therapy alone for methamphetamine use disorder …